| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.004 | 0.796 | Cardiotonic | 0.77 0.004 CID_107858 | ||
| 0.778 | 0.004 | 0.778 | Spasmolytic | 0.744 0.005 CID_107858 | ||
| 0.701 | 0.005 | 0.701 | Potassium channel (Voltage-sensitive) blocker | 0.551 0.01 CID_107858 | ||
| 0.674 | 0.005 | 0.686 | Hypoglycemic | 0.686 0.005 CID_107858 | CID_107858 | |
| 0.664 | 0.011 | 0.664 | Toll-Like receptor agonist | 0.58 0.019 CID_107858 | ||
| 0.656 | 0.005 | 0.656 | HERG channel blocker | 0.497 0.015 CID_107858 | ||
| 0.661 | 0.011 | 0.661 | Toll-Like receptor 7 agonist | 0.576 0.02 CID_107858 | ||
| 0.589 | 0.006 | 0.632 | Vasodilator | 0.632 0.005 CID_107858 | CID_107858 | |
| 0.573 | 0.004 | 0.573 | Cholinergic antagonist | 0.459 0.005 CID_107858 | ||
| 0.568 | 0.004 | 0.568 | Acetylcholine antagonist | 0.452 0.005 CID_107858 | ||
| 0.568 | 0.007 | 0.568 | Potassium channel blocker | 0.431 0.018 CID_107858 | ||
| 0.483 | 0.004 | 0.483 | Acetylcholine M1 receptor antagonist | 0.407 0.005 CID_107858 | ||
| 0.473 | 0.004 | 0.473 | Acetylcholine muscarinic antagonist | 0.38 0.005 CID_107858 | ||
| 0.343 | 0.004 | 0.343 | Uric acid excretion stimulant | 0.339 0.005 CID_107858 | ||
| 0.394 | 0.094 | 0.447 | Cyclophilin D inhibitor | 0.447 0.068 CID_107858 | CID_107858 | |
| 0.291 | 0.054 | 0.344 | Superoxide dismutase inhibitor | 0.344 0.038 CID_107858 | CID_107858 | |
| 0.24 | 0.005 | 0.24 | Thioredoxin inhibitor | 0.236 0.005 CID_107858 | ||
| 0.288 | 0.054 | 0.29 | Ca(v)3.3 blocker | 0.29 0.051 CID_107858 | CID_107858 | |
| 0.247 | 0.019 | 0.247 | Sodium channel blocker | 0.216 0.027 CID_107858 | ||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | 0.296 0.135 CID_107858 | ||
| 0.334 | 0.17 | 0.374 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.374 0.125 CID_107858 | CID_107858 | |
| 0.242 | 0.089 | 0.289 | 5 Hydroxytryptamine uptake stimulant | 0.289 0.051 CID_107858 | CID_107858 | |
| 0.187 | 0.036 | 0.187 | Anesthetic local | 0.149 0.049 CID_107858 | ||
| 0.155 | 0.011 | 0.155 | Acetylcholine M3 receptor antagonist | 0.092 0.021 CID_107858 | ||
| 0.244 | 0.102 | 0.255 | Insulysin inhibitor | 0.255 0.092 CID_107858 | CID_107858 | |
| 0.159 | 0.019 | 0.159 | Porphobilinogen synthase inhibitor | 0.124 0.027 CID_107858 | ||
| 0.151 | 0.011 | 0.151 | Acetylcholine M2 receptor antagonist | 0.109 0.019 CID_107858 | ||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.147 | 0.018 | 0.147 | Acetylcholine release stimulant | 0.108 0.07 CID_107858 | ||
| 0.13 | 0.019 | 0.13 | Analgesic, opioid | 0.097 0.033 CID_107858 | ||
| 0.118 | 0.013 | 0.118 | Acetylcholine M5 receptor antagonist | 0.064 0.037 CID_107858 | ||
| 0.151 | 0.053 | 0.151 | Nav1.6 sodium channel blocker | 0.135 0.073 CID_107858 | ||
| 0.108 | 0.022 | 0.108 | Thioredoxin reductase inhibitor | 0.098 0.03 CID_107858 | ||
| 0.202 | 0.116 | 0.222 | Neuropeptide Y2 antagonist | 0.222 0.086 CID_107858 | CID_107858 | |
| 0.277 | 0.192 | 0.277 | 5 Hydroxytryptamine release inhibitor | 0.277 0.192 CID_107858 | ||
| 0.108 | 0.023 | 0.108 | Acetylcholine M4 receptor antagonist | |||
| 0.213 | 0.129 | 0.216 | Gastrin inhibitor | 0.216 0.126 CID_107858 | CID_107858 | |
| 0.22 | 0.145 | 0.22 | Thyroid hormone antagonist | |||
| 0.099 | 0.028 | 0.119 | Aminopeptidase I inhibitor | 0.119 0.02 CID_107858 | CID_107858 | |
| 0.155 | 0.089 | 0.185 | Antipruritic | 0.185 0.06 CID_107858 | CID_107858 | |
| 0.105 | 0.042 | 0.105 | Histamine N-methyltransferase inhibitor | 0.076 0.072 CID_107858 | ||
| 0.162 | 0.106 | 0.333 | Psychostimulant | 0.333 0.035 CID_107858 | CID_107858 | |
| 0.182 | 0.126 | 0.216 | Peptidyltransferase inhibitor | 0.216 0.08 CID_107858 | CID_107858 | |
| 0.095 | 0.042 | 0.098 | Hematopoietic | 0.098 0.038 CID_107858 | CID_107858 | |
| 0.186 | 0.134 | 0.393 | 5 Hydroxytryptamine release stimulant | 0.393 0.047 CID_107858 | CID_107858 | |
| 0.144 | 0.092 | 0.185 | Growth hormone agonist | 0.185 0.065 CID_107858 | CID_107858 | |
| 0.123 | 0.071 | 0.155 | Nav1.3 sodium channel blocker | 0.155 0.045 CID_107858 | CID_107858 | |
| 0.09 | 0.041 | 0.138 | Somatostatin 1 agonist | 0.138 0.017 CID_107858 | CID_107858 | |
| 0.091 | 0.045 | 0.091 | Acetylcholine nicotinic antagonist | 0.082 0.053 CID_107858 | ||
| 0.058 | 0.015 | 0.083 | Histamine H2 receptor agonist | 0.083 0.006 CID_107858 | CID_107858 | |
| 0.055 | 0.013 | 0.075 | Histamine H1 receptor agonist | 0.075 0.004 CID_107858 | CID_107858 | |
| 0.054 | 0.017 | 0.054 | GHS receptor agonist | |||
| 0.195 | 0.158 | 0.195 | Thyroid hormone beta antagonist | |||
| 0.068 | 0.031 | 0.078 | Histone deacetylase SIRT3 inhibitor | 0.078 0.019 CID_107858 | CID_107858 | |
| 0.19 | 0.155 | 0.19 | MAP kinase kinase 3 inhibitor | 0.188 0.16 CID_107858 | ||
| 0.064 | 0.037 | 0.072 | Bombesin 1 receptor agonist | 0.072 0.03 CID_107858 | CID_107858 | |
| 0.046 | 0.019 | 0.046 | Factor XIIIa inhibitor | 0.036 0.027 CID_107858 | ||
| 0.046 | 0.022 | 0.046 | Plasmepsin II inhibitor | 0.039 0.032 CID_107858 | ||
| 0.082 | 0.06 | 0.094 | Histamine H2 receptor antagonist | 0.094 0.041 CID_107858 | CID_107858 | |
| 0.052 | 0.035 | 0.052 | Vanilloid 2 antagonist | |||
| 0.108 | 0.093 | 0.137 | Cathepsin H inhibitor | 0.137 0.057 CID_107858 | CID_107858 | |
| 0.054 | 0.04 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.03 CID_107858 | CID_107858 | |
| 0.084 | 0.071 | 0.091 | Antihistaminic | 0.091 0.063 CID_107858 | CID_107858 | |
| 0.071 | 0.058 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.053 CID_107858 | CID_107858 | |
| 0.034 | 0.022 | 0.034 | Growth hormone releasing factor agonist | |||
| 0.055 | 0.046 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 CID_107858 | CID_107858 | |
| 0.084 | 0.078 | 0.116 | Aminopeptidase B inhibitor | 0.116 0.055 CID_107858 | CID_107858 | |
| 0.015 | 0.008 | 0.015 | 5 Lipoxygenase activating protein inhibitor | 0.014 0.009 CID_107858 | ||
| 0.056 | 0.05 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.058 | 0.052 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.075 | 0.07 | 0.082 | Histamine antagonist | 0.082 0.062 CID_107858 | CID_107858 | |
| 0.047 | 0.043 | 0.073 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.027 CID_107858 | CID_107858 | |
| 0.053 | 0.05 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 CID_107858 | CID_107858 | |
| 0.047 | 0.044 | 0.074 | Ribonucleotide reductase inhibitor | 0.074 0.029 CID_107858 | CID_107858 | |
| 0.092 | 0.092 | 0.127 | Factor V inhibitor | 0.127 0.032 CID_107858 | CID_107858 | |
| 0.003 | 0.005 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 CID_107858 | CID_107858 | |
| 0.049 | 0.053 | 0.076 | CXC chemokine 4 receptor antagonist | 0.076 0.033 CID_107858 | CID_107858 | |
| 0.032 | 0.042 | 0.04 | Glutamate (mGluR1a) antagonist | 0.04 0.029 CID_107858 | CID_107858 | |
| 0.078 | 0.09 | 0.089 | Creatine kinase inhibitor | 0.089 0.074 CID_107858 | CID_107858 | |
| 0.022 | 0.034 | 0.031 | Plasmepsin I inhibitor | 0.031 0.02 CID_107858 | CID_107858 | |
| 0.025 | 0.039 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_107858 | CID_107858 | |
| 0.055 | 0.074 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.047 CID_107858 | CID_107858 | |
| 0.033 | 0.054 | 0.051 | Geranyltranstransferase inhibitor | 0.051 0.021 CID_107858 | CID_107858 | |
| 0.029 | 0.05 | 0.047 | Oxytocin agonist | 0.047 0.026 CID_107858 | CID_107858 | |
| 0.026 | 0.048 | 0.035 | Diamine oxidase inhibitor | 0.035 0.029 CID_107858 | CID_107858 | |
| 0.152 | 0.176 | 0.188 | Calpain inhibitor | 0.188 0.125 CID_107858 | CID_107858 | |
| 0.039 | 0.064 | 0.075 | Histamine agonist | 0.075 0.016 CID_107858 | CID_107858 | |
| 0.114 | 0.139 | 0.156 | Adenylate cyclase stimulant | 0.156 0.053 CID_107858 | CID_107858 | |
| 0.038 | 0.066 | 0.048 | Bombesin 2 receptor antagonist | 0.048 0.036 CID_107858 | CID_107858 | |
| 0.023 | 0.054 | 0.033 | Melanocortin 1 antagonist | 0.033 0.031 CID_107858 | CID_107858 | |
| 0.08 | 0.119 | 0.1 | Proteasome inhibitor | 0.1 0.087 CID_107858 | CID_107858 | |
| 0.017 | 0.06 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.021 CID_107858 | CID_107858 | |
| 0.076 | 0.127 | 0.1 | Nav1.4 sodium channel blocker | 0.1 0.076 CID_107858 | CID_107858 | |
| 0.088 | 0.144 | 0.129 | Histone deacetylase SIRT1 inhibitor | 0.129 0.081 CID_107858 | CID_107858 | |
| 0.029 | 0.087 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 CID_107858 | CID_107858 | |
| 0.044 | 0.108 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.048 CID_107858 | CID_107858 | |
| 0.123 | 0.187 | 0.16 | Neurotensin receptor agonist | 0.16 0.079 CID_107858 | CID_107858 | |
| 0.066 | 0.136 | 0.086 | Nitric-oxide synthase inhibitor | 0.086 0.085 CID_107858 | CID_107858 | |
| 0.013 | 0.083 | 0.036 | Gonadotropin-releasing hormone receptor antagonist | 0.036 0.023 CID_107858 | CID_107858 | |
| 0.032 | 0.102 | 0.088 | Myc inhibitor | 0.088 0.01 CID_107858 | CID_107858 | |
| 0.063 | 0.161 | 0.101 | Histone deacetylase class III inhibitor | 0.101 0.089 CID_107858 | CID_107858 | |
| 0.147 | 0.246 | 0.227 | Vasodilator, coronary | 0.227 0.157 CID_107858 | CID_107858 | |
| 0.087 | 0.2 | 0.134 | Thiol protease inhibitor | 0.134 0.09 CID_107858 | CID_107858 | |
| 0.03 | 0.149 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 CID_107858 | CID_107858 | |
| 0.157 | 0.334 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.181 CID_107858 | CID_107858 | |
| 0.123 | 0.325 | 0.303 | Sodium/bile acid cotransporter inhibitor | 0.303 0.076 CID_107858 | CID_107858 | |
| 0.056 | 0.324 | 0.126 | Neuropeptide Y1 antagonist | 0.126 0.109 CID_107858 | CID_107858 | |
| 0.024 | 0.365 | 0.097 | Bronchodilator | 0.097 0.068 CID_107858 | CID_107858 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |